Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

245 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Green tea: prevention and treatment of cancer by nutraceuticals.
Béliveau R, Gingras D. Béliveau R, et al. Lancet. 2004 Sep 18-24;364(9439):1021-2. doi: 10.1016/S0140-6736(04)17076-1. Lancet. 2004. PMID: 15380952 No abstract available.
Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling.
Lamy S, Beaulieu E, Labbé D, Bédard V, Moghrabi A, Barrette S, Gingras D, Béliveau R. Lamy S, et al. Among authors: beliveau r. Carcinogenesis. 2008 May;29(5):1033-41. doi: 10.1093/carcin/bgn070. Epub 2008 Mar 13. Carcinogenesis. 2008. PMID: 18339683
Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation.
Lamy S, Blanchette M, Michaud-Levesque J, Lafleur R, Durocher Y, Moghrabi A, Barrette S, Gingras D, Béliveau R. Lamy S, et al. Among authors: beliveau r. Carcinogenesis. 2006 May;27(5):989-96. doi: 10.1093/carcin/bgi279. Epub 2005 Nov 23. Carcinogenesis. 2006. PMID: 16308314
Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation.
Langlois S, Gingras D, Béliveau R. Langlois S, et al. Among authors: beliveau r. Blood. 2004 Apr 15;103(8):3020-8. doi: 10.1182/blood-2003-08-2968. Epub 2003 Dec 11. Blood. 2004. PMID: 15070679
Neovastat--a novel antiangiogenic drug for cancer therapy.
Gingras D, Boivin D, Deckers C, Gendron S, Barthomeuf C, Béliveau R. Gingras D, et al. Among authors: beliveau r. Anticancer Drugs. 2003 Feb;14(2):91-6. doi: 10.1097/00001813-200302000-00001. Anticancer Drugs. 2003. PMID: 12569294 Review.
Inhibition of tumor growth by a truncated and soluble form of melanotransferrin.
Rolland Y, Demeule M, Michaud-Levesque J, Béliveau R. Rolland Y, et al. Among authors: beliveau r. Exp Cell Res. 2007 Aug 1;313(13):2910-9. doi: 10.1016/j.yexcr.2007.04.013. Epub 2007 Apr 14. Exp Cell Res. 2007. PMID: 17493610
Combined low dose ionizing radiation and green tea-derived epigallocatechin-3-gallate treatment induces human brain endothelial cells death.
McLaughlin N, Annabi B, Lachambre MP, Kim KS, Bahary JP, Moumdjian R, Béliveau R. McLaughlin N, et al. Among authors: beliveau r. J Neurooncol. 2006 Nov;80(2):111-21. doi: 10.1007/s11060-006-9171-8. Epub 2006 May 19. J Neurooncol. 2006. PMID: 16715350
Medulloblastoma cell invasion is inhibited by green tea (-)epigallocatechin-3-gallate.
Pilorget A, Berthet V, Luis J, Moghrabi A, Annabi B, Béliveau R. Pilorget A, et al. Among authors: beliveau r. J Cell Biochem. 2003 Nov 1;90(4):745-55. doi: 10.1002/jcb.10667. J Cell Biochem. 2003. PMID: 14587030
Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg.
Annabi B, Currie JC, Moghrabi A, Béliveau R. Annabi B, et al. Among authors: beliveau r. Leuk Res. 2007 Sep;31(9):1277-84. doi: 10.1016/j.leukres.2006.10.001. Epub 2006 Nov 1. Leuk Res. 2007. PMID: 17081606
Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling.
Annabi B, Bouzeghrane M, Currie JC, Dulude H, Daigneault L, Garde S, Rabbani SA, Panchal C, Wu JJ, Béliveau R. Annabi B, et al. Among authors: beliveau r. Anticancer Drugs. 2006 Apr;17(4):429-38. doi: 10.1097/01.cad.0000203388.68034.06. Anticancer Drugs. 2006. PMID: 16550001
245 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback